Emerald Advisers, LLC Corcept Therapeutics Inc Transaction History
Emerald Advisers, LLC
- $2.53 Billion
- Q2 2025
A detailed history of Emerald Advisers, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Emerald Advisers, LLC holds 242,053 shares of CORT stock, worth $19 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
242,053
Previous 62,182
289.27%
Holding current value
$19 Million
Previous $7.1 Million
150.15%
% of portfolio
0.7%
Previous 0.35%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
477Shares Held
83.5MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.3 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$761 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$607 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$493 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$304 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.42B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...